Mcrae Capital Management Inc. purchased a new position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) in the 3rd quarter, HoldingsChannel reports. The firm purchased 3,085 shares of the pharmacy operator’s stock, valued at approximately $225,000.
Other hedge funds also recently modified their holdings of the company. BlueMountain Capital Management LLC purchased a new stake in Walgreens Boots Alliance during the second quarter worth approximately $103,000. CSat Investment Advisory L.P. purchased a new stake in Walgreens Boots Alliance during the second quarter worth approximately $104,000. Squar Milner Financial Services LLC purchased a new stake in Walgreens Boots Alliance during the second quarter worth approximately $106,000. Kaizen Advisory LLC grew its stake in Walgreens Boots Alliance by 128.6% during the second quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after buying an additional 1,083 shares during the period. Finally, Camarda Financial Advisors LLC purchased a new stake in Walgreens Boots Alliance during the second quarter worth approximately $137,000. 61.92% of the stock is owned by hedge funds and other institutional investors.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the stock in a transaction on Thursday, August 2nd. The shares were sold at an average price of $65.99, for a total transaction of $180,548.64. Following the transaction, the director now directly owns 10,943 shares in the company, valued at approximately $722,128.57. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 14.80% of the company’s stock.
NASDAQ WBA traded up $1.22 during trading hours on Monday, reaching $74.72. 8,324,300 shares of the company traded hands, compared to its average volume of 6,238,140. Walgreens Boots Alliance Inc has a 12 month low of $59.07 and a 12 month high of $80.68. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.93 and a quick ratio of 0.47. The company has a market capitalization of $72.35 billion, a price-to-earnings ratio of 14.65, a price-to-earnings-growth ratio of 1.11 and a beta of 1.04.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, beating the Zacks’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a net margin of 3.36% and a return on equity of 21.22%. The firm had revenue of $33.44 billion for the quarter, compared to the consensus estimate of $33.64 billion. As a group, analysts anticipate that Walgreens Boots Alliance Inc will post 5.98 EPS for the current year.
Several research analysts have recently weighed in on WBA shares. Pivotal Research upped their target price on shares of Walgreens Boots Alliance from $60.00 to $72.00 and gave the company a “hold” rating in a research note on Monday. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $79.00 target price for the company in a research note on Saturday. Barclays upped their target price on shares of Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a research note on Friday. Robert W. Baird upped their target price on shares of Walgreens Boots Alliance from $69.00 to $71.00 and gave the company a “neutral” rating in a research note on Friday. Finally, Citigroup upped their target price on shares of Walgreens Boots Alliance from $69.00 to $76.00 and gave the company a “neutral” rating in a research note on Friday. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $78.22.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
See Also: Google Finance Portfolio
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.